Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis

Maureen J. Aarts,Birgit E.P.J. Vriens,Maaike de Boer,Frank P. J. Peters,Caroline M.P.W. Mandigers,M. Wouter Dercksen,Jacqueline Stouthard,Jolien Tol,Laurence J. C. van Warmerdam,Agnes J. van de Wouw,Esther M. Jacobs,Carin C. D. van der Rij,Tineke J. Smilde,Annette W. van der Velden,Nelly Peer,Vivianne C. G. Tjan-Heijnen

Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis

2017

Maureen J. Aarts
Birgit E.P.J. Vriens
Maaike de Boer
Frank P. J. Peters
Caroline M.P.W. Mandigers
M. Wouter Dercksen
Jacqueline Stouthard
Jolien Tol
Laurence J. C. van Warmerdam
Agnes J. van de Wouw
Esther M. Jacobs
Carin C. D. van der Rij
Tineke J. Smilde
Annette W. van der Velden
Nelly Peer
Vivianne C. G. Tjan-Heijnen

Objective: The primary outcome of the current study is, whether there is a protective effect of prior chemotherapy or of prior granulocyte colony-stimulating fact

Keywords:

Breast cancer
Granulocyte
Immunology
Medicine
Granulocyte colony-stimulating factor
Chemotherapy
Neutrophil recovery
Pegfilgrastim
Docetaxel
Pharmacokinetics
Neutropenia
Absolute neutrophil count
White blood cell
Febrile neutropenia

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations